Clinical drug development for childhood cancers.
作者： FM Balis , E Fox , BC Widemann , PC Adamson
关键词:
摘要:
elsevier.com
nature.com
sci-hub.se 参考文章(3)
William M. Crist, James R. Anderson, Jane L. Meza, Christopher Fryer, R. Beverly Raney, Frederick B. Ruymann, John Breneman, Stephen J. Qualman, Eugene Wiener, Moody Wharam, Thom Lobe, Bruce Webber, Harold M. Maurer, Sarah S. Donaldson, Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease Journal of Clinical Oncology. ,vol. 19, pp. 3091- 3102 ,(2001) , 10.1200/JCO.2001.19.12.3091
Debra P. Lee, Jeffrey M. Skolnik, Peter C. Adamson, Pediatric Phase I Trials in Oncology: An Analysis of Study Conduct Efficiency Journal of Clinical Oncology. ,vol. 23, pp. 8431- 8441 ,(2005) , 10.1200/JCO.2005.02.1568
Alberto S. Pappo, Elizabeth Lyden, Phillip Breitfeld, Sarah S. Donaldson, Eugene Wiener, David Parham, Kristine R. Crews, Peter Houghton, William H. Meyer, Two Consecutive Phase II Window Trials of Irinotecan Alone or in Combination With Vincristine for the Treatment of Metastatic Rhabdomyosarcoma: The Children's Oncology Group Journal of Clinical Oncology. ,vol. 25, pp. 362- 369 ,(2007) , 10.1200/JCO.2006.07.1720